Dr. Cotsarelis New Discovery that may finally cure Baldness (June 3rd, 2013)

Collapse
X
 
  • Time
  • Show
Clear All
new posts

  • bigentries
    replied
    Originally posted by UK_
    Articles are cropping up now.

    This one also mentions WNT proteins and their relation to FGF9:



    Obviously according to some forum members at TBT (bigentries) the work of Histogen into follicular neogenesis using Wnt proteins is all bunk, and the company should be starved of any financial support.

    Any thoughts bigentries? Any thoughts?
    That's a Follica article...

    I don't see how Histogen failing in their Phase II results has anything to do with that article or a future Wnt-related cure

    Leave a comment:


  • UK_
    replied
    Articles are cropping up now.

    This one also mentions WNT proteins and their relation to FGF9:



    Obviously according to some forum members at TBT (bigentries) the work of Histogen into follicular neogenesis using Wnt proteins is all bunk, and the company should be starved of any financial support.

    Any thoughts bigentries? Any thoughts?

    Leave a comment:


  • Breaking Bald
    replied
    Originally posted by Desmond84
    UK I don't know when xconomy edited their article, but they just added this in there:

    [An earlier version of this story indicated that Follica used that protein, Fgf9, in its clinical trial. Olle later clarified that the protein, Fgf9, has only been involved in Follica's preclinical work so far].

    So, FGF-9 never made it to human trials! It was being used in their pre-clinical studies prior to their Phae I/II trials (i.e. they only tested it in mice)...

    That's OK though! They're onto something for sure
    I'm not trying to highlight the negatives here, obviously this is very interesting. But if no human trials have been conducted yet, then is is likely to be 3 years or so away?

    All of this hype and secretiveness is very irritating, I would prefer that they told us about amazing news closer to the time of release.

    Leave a comment:


  • Desmond84
    replied
    UK I don't know when xconomy edited their article, but they just added this in there:

    [An earlier version of this story indicated that Follica used that protein, Fgf9, in its clinical trial. Olle later clarified that the protein, Fgf9, has only been involved in Follica's preclinical work so far].

    So, FGF-9 never made it to human trials! It was being used in their pre-clinical studies prior to their Phae I/II trials (i.e. they only tested it in mice)...

    That's OK though! They're onto something for sure

    Leave a comment:


  • Desmond84
    replied
    OK, a good friend just forwarded the Nature article to me!

    This was definitely a mouse study! But here's the interesting part, when they used Doxycycline on the mice, the amount of FGF-9 expression increased by 150-fold!

    Maybe this is the novel therapy Follica is going to experiment with now! Wounding + Doxycyline!

    Just a thought

    Leave a comment:


  • UK_
    replied
    Originally posted by Desmond84
    Hmmm, Hariri all those 3 links use the Nature Medicine article as their reference!



    They also mention that these new findings were conducted in mice...they still need to conduct a small human trial to test for efficacy!

    So the first step is to culture dermal γδ T cells in a lab and then get them to produce lots of FGF-9 in order to inject them into patient's scalp.

    This is a very recent finding...I really doubt they would have conducted a Phase 2 trial on this stuff back in 2010, but I may be wrong
    No they dont, they're just not discussing in any detail their human trials, they wont even tell people where they're being conducted, here:


    Xconomy:

    Follica said in its statement that it has already done preclinical tests that combine devices it has created to disrupt the skin with several unspecified “known and novel drugs.” It also claims to have run “a series” of human clinical trials, including a mid-stage study that has caused new hair follicles to be produced in humans. Unfortunately for our rabid readers, however, Olle and Follica aren’t offering many details from these studies, other than to indicate that the platform is proving to work so far and that the research has paved the way for the company’s next step: to try a specific device configuration with a specific, well-known and studied drug (meaning it wouldn’t have to be as extensively tested as a new chemical) in a group of human patients.

    “We’ve been able to consistently show that we create substantial new hair follicles in humans, and that’s something that no other approach in hair loss as far as I am aware has been able to achieve,” Olle says. “That’s a critical step. The goal of some of those early trials has been to test the hypothesis of the mechanism that we had seen in mice.”
    I really hope this sends a clear message to Aderans, because it looks like any moment Follica could come out with something which will make Aderans' decade long research agenda completely pointless. Oh well, that's what you get for dragging your feet and keeping your future customers in limbo for all these years.

    To the poster before who stated this wouldnt help as the new hair would still be vulnerable to DHT, well there's an obvious procedure that would benefit from a discovery like this. If the scalp requires wounding and then an application of a certain agent to induce neogenesis then clearly, a set of 3 hair transplant sessions with 4000 grafts each should become a norm with 100% donor regeneration. A finding like this would extend the work of Dr Gho to 100% full donor regeneration and a true limitless supply of grafts that are all DHT resistant.

    Leave a comment:


  • UK_
    replied
    Thanks for that, I noticed how you put the xconomy one at the top lol - probably the most insightful IMO.

    Leave a comment:


  • Desmond84
    replied
    Hmmm, Hariri all those 3 links use the Nature Medicine article as their reference!



    They also mention that these new findings were conducted in mice...they still need to conduct a small human trial to test for efficacy!

    So the first step is to culture dermal γδ T cells in a lab and then get them to produce lots of FGF-9 in order to inject them into patient's scalp.

    This is a very recent finding...I really doubt they would have conducted a Phase 2 trial on this stuff back in 2010, but I may be wrong

    Leave a comment:


  • HARIRI
    replied
    Articles about Follica Breakthrough...

    1- http://www.xconomy.com/boston/2013/0...dness-therapy/

    2- http://www.marketwatch.com/story/new...ess-2013-06-03

    3- http://www.follicabio.com/news/folli...stigationi-44/

    Leave a comment:


  • UK_
    replied
    Originally posted by Dazza
    Apparently this is not the correct phase 2a trial. this was a separate one that run in conjunction.

    Quoting from a poster at HS
    Follica conducted two different studies that we know of. One had wounding and no topical compound, the other had wounding with a topical compound (Lithium). The former actually exhibited modest hair growth. We still have no indication of efficacy for the latter.

    Follica do not make this easy to follow lol.
    Well we have some indication here:

    Leave a comment:


  • UK_
    replied
    Originally posted by Desmond84
    Hey brother

    Welcome to BTT...so this study that was published was conducted in humans! That is definitely worth a read!!!

    Guys is anyone able to access this article and either post it on this site or email it to me or anyone you like...let's see if it is really as ground breaking as everyone thinks it is...here's the link:



    Thanks in advance btw
    That article you linked us to isnt what they're talking about in the following segment:

    Follica has conducted preclinical testing of proprietary device configurations for skin disruption in combination with a number of known and novel drugs. The company has run a series of human clinical trials, including a Phase IIa trial, which have demonstrated follicular neogenesis in humans for the first time. These trials pave the way for the development of a breakthrough combination of a device to produce targeted skin perturbation coupled with a well-studied drug compound.
    Follica have run a number of human trials based upon the theoretical work associated with mouse studies and FGF9 including a human preclinical trial, that particular work is not related to the link you posted. Follica are immensely secretive, it's very difficult to know exactly what they're up to, however I have never seen them come out and state in a news release they have shown human hair follicle regeneration, that is important to note.

    Leave a comment:


  • Desmond84
    replied
    Originally posted by hairandthere
    First post here. Hi Desmond. I'm definitely not here to antagonize. I appreciate very much the information that you bring to light on this forum.

    Are you saying that the media releases and statements made by one of the Follica co-founders are fabricated? Or did you just miss the information that they have grown a new hair follicle in a human for the first time in history?

    http://www.xconomy.com/boston/2013/0...dness-therapy/
    Hey brother

    Welcome to BTT...so this study that was published was conducted in humans! That is definitely worth a read!!!

    Guys is anyone able to access this article and either post it on this site or email it to me or anyone you like...let's see if it is really as ground breaking as everyone thinks it is...here's the link:



    Thanks in advance btw

    Leave a comment:


  • Dazza
    replied
    Originally posted by Dazza
    Apparently this is not the correct phase 2a trial. this was a separate one that run in conjunction.

    Quoting from a poster at HS
    Follica conducted two different studies that we know of. One had wounding and no topical compound, the other had wounding with a topical compound (Lithium). The former actually exhibited modest hair growth. We still have no indication of efficacy for the latter.

    Follica do not make this easy to follow lol.

    Leave a comment:


  • Dazza
    replied
    Originally posted by UK_
    What old trials? Can you provide the to - from date of the trials you're talking about?

    As far as I can tell, they gained approval and patented a number of compounds back in 2010 (one of them being lithium) and began A clinical trial in that year, now we have the results of that trial.

    How is this news therefore related to old findings and old trials?

    2% increase in terminal hairs, tho neogenesis was achieved

    Leave a comment:


  • UK_
    replied
    Originally posted by Dazza
    The results they are talking about are from their old trials regarding wounding and lithium which they did grow new hair follicles.

    NOT from FgF-9. They have only tested this in mice.

    smart journalism
    What old trials? Can you provide the from-to dates of the trials you're talking about?

    As far as I can tell, they gained approval and patented a number of compounds back in 2010 (one of them being lithium for hair loss) and began A clinical trial in that year, now we have the results of that trial.

    How is this news therefore related to old findings of old trials? FGF9 is part of the entire hypothesis - the compounds used are clearly aimed at altering the gene in question as the following clearly states:

    "This discovery sheds light on a novel mechanism to regenerate hair follicles and opens an exciting new avenue to develop treatments for hair loss in humans," noted Dr. William Ju of Follica, Inc. "Follica has developed a technology platform that is uniquely suited to support clinical translation of these new findings. The Follica platform can be used to induce skin reepithelialization, which creates a "window of opportunity" during which the Fgf9 pathway could be modulated to potentiate hair neogenesis."

    Leave a comment:

Working...